Skip to main content
Top

04-01-2025 | Irritable Bowel Syndrome | Original Research Article

Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study

Authors: Kathleen Manipis, Paula Cronin, Deborah Street, Jody Church, Rosalie Viney, Stephen Goodall

Published in: PharmacoEconomics

Login to get access

Abstract

Background

Cost-utility analyses commonly use two primary methods to value productivity: the human capital approach (HCA) and the friction cost approach (FCA). Another less frequently used method is the willingness-to-pay (WTP) approach, which estimates the monetary value individuals assign to avoiding an illness. In the context of foodborne illnesses (FBI), productivity loss represents one of the most significant economic impacts, particularly in developed nations. These losses arise from factors such as missed workdays, reduced workplace efficiency due to illness, and long-term health complications that can limit an individual’s ability to work. As a result, accurately quantifying productivity loss is critical in understanding the broader economic burden of FBI.

Aim

Our aim was to compare the impact of valuation methods used to measure productivity loss in an economic evaluation, using a hypothetical intervention for FBI caused by campylobacter as a case study. Cost effectiveness from three perspectives is examined: health care system, employee, and employer.

Method

A Markov model with a 10-year time horizon was developed to evaluate the morbidity and productivity impacts of FBI caused by campylobacter. The model included four health states: ‘healthy’, ‘acute gastroenteritis’, ‘irritable bowel syndrome and being unable to work some of the time’, and ‘irritable bowel syndrome and unable to work’. Five approaches to valuing productivity loss were compared: model 1 (cost-utility analysis), model 2 (HCA), model 3 (FCA), model 4 (FCA+WTP to avoid illness with paid sick leave), and model 5 (WTP to avoid illness without paid sick leave). Health outcomes and costs were discounted using a 5% discount rate. Costs were reported in 2024 Australian dollars ($AUD).

Results

Model 1, which did not include productivity losses, yielded the highest incremental cost-effectiveness ratio (ICER) at $56,467 per quality-adjusted life-year (QALY) gained. The inclusion of productivity costs (models 2–5) significantly increased the total costs in both arms of the models but led to a marked reduction in the ICERs. For example, model 2 (HCA) resulted in an ICER of $11,174/QALY gained, whereas model 3 (FCA) resulted in $21,136/QALY gained. Models 4 and 5, which included WTP approaches, had ICERs of $19,661/QALY gained and $24,773/QALY gained, respectively.

Conclusion

These findings underscore the significant impact of different modelling approaches to productivity loss on ICER estimates and consequently the decision to adopt a new policy or intervention. The choice of perspective in the analysis is critical, as it determines how the short-term and long-term productivity losses are accounted for and valued. This highlights the importance of carefully selecting and justifying the perspective and valuation methods used in economic evaluations to ensure informed and balanced policy decisions.
Appendix
Available only for authorised users
Literature
2.
go back to reference Grosse SD, Krueger KV, Pike J. Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations. J Med Econ. 2019;22(6):501–8.CrossRefPubMed Grosse SD, Krueger KV, Pike J. Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations. J Med Econ. 2019;22(6):501–8.CrossRefPubMed
5.
go back to reference Knies S, et al. The transferability of valuing lost productivity across jurisdictions. Differences between national pharmacoeconomic guidelines. Value Health. 2010;13(5):519–27.CrossRefPubMed Knies S, et al. The transferability of valuing lost productivity across jurisdictions. Differences between national pharmacoeconomic guidelines. Value Health. 2010;13(5):519–27.CrossRefPubMed
12.
go back to reference Manipis K, et al. Health technology assessment methods: economic evaluation in Australian health technology assessment methods and policy review. Canberra: Australian Government Department of Health and Aged Care, Editor; 2023 Manipis K, et al. Health technology assessment methods: economic evaluation in Australian health technology assessment methods and policy review. Canberra: Australian Government Department of Health and Aged Care, Editor; 2023
13.
go back to reference McIntosh E, et al. Applied methods of cost-benefit analysis in health care. Oxford: OUP Oxford; 2010. McIntosh E, et al. Applied methods of cost-benefit analysis in health care. Oxford: OUP Oxford; 2010.
22.
go back to reference Australian Government, Fair Work Act 2009 (Cth). 2019. Australian Government, Fair Work Act 2009 (Cth). 2019.
24.
go back to reference Kirk M, et al. Foodborne illness in Australia: Annual incidence circa 2010. Canberra: Australian Government Department of Health, editor; 2014. Kirk M, et al. Foodborne illness in Australia: Annual incidence circa 2010. Canberra: Australian Government Department of Health, editor; 2014.
27.
go back to reference Abelson P. The annual cost of foodborne illness in Australia. Canberra: Canberra Australian Government Department of Health and Ageing; 2006. Abelson P. The annual cost of foodborne illness in Australia. Canberra: Canberra Australian Government Department of Health and Ageing; 2006.
32.
36.
go back to reference Australian Government. Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee (PBAC Guidelines), version 5.0. Canberra: Department of Health, editor; 2016. Australian Government. Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee (PBAC Guidelines), version 5.0. Canberra: Department of Health, editor; 2016.
43.
go back to reference Food Standards Australia New Zealand. Health and hygiene for food handlers. FSANZ, Editor; 2021. Food Standards Australia New Zealand. Health and hygiene for food handlers. FSANZ, Editor; 2021.
45.
go back to reference Australian Government. Australian national notifiable diseases and case definitions. Canberra: Department of Health, editor; 2021. Australian Government. Australian national notifiable diseases and case definitions. Canberra: Department of Health, editor; 2021.
62.
go back to reference Australian Government. Average Weekly Earnings, Australia, November 2019. Canberra: Australian Bureau of Statistics, editor; 2019. Australian Government. Average Weekly Earnings, Australia, November 2019. Canberra: Australian Bureau of Statistics, editor; 2019.
69.
go back to reference Australian Bureau of Statistics, 6333.0.00.001 - Microdata: Characteristics of Employment, Australia, August 2019. Canberra; Bureau of Statistics; 2019. Australian Bureau of Statistics, 6333.0.00.001 - Microdata: Characteristics of Employment, Australia, August 2019. Canberra; Bureau of Statistics; 2019.
72.
go back to reference Breidert C, Hahsler M, Reutterer T. A review of methods for measuring willingness-to-pay. Innov Mark. 2015;2:8–32. Breidert C, Hahsler M, Reutterer T. A review of methods for measuring willingness-to-pay. Innov Mark. 2015;2:8–32.
Metadata
Title
Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study
Authors
Kathleen Manipis
Paula Cronin
Deborah Street
Jody Church
Rosalie Viney
Stephen Goodall
Publication date
04-01-2025
Publisher
Springer International Publishing
Published in
PharmacoEconomics
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.1007/s40273-024-01458-9